Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers Sells 8,712 Shares

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 8,712 shares of the stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total value of $588,669.84. Following the sale, the chief financial officer now owns 221,100 shares in the company, valued at approximately $14,939,727. This represents a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

James William Rogers also recently made the following trade(s):

• On Monday, December 16th, James William Rogers sold 1,468 shares of Tempus AI stock. The shares were sold at an average price of $40.23, for a total value of $59,057.64.
• On Wednesday, December 11th, James William Rogers sold 83,025 shares of Tempus AI stock. The stock was sold at an average price of $42.30, for a total value of $3,511,957.50.

Tempus AI Stock Performance

NASDAQ TEM opened at $68.96 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49. The company’s 50 day moving average is $44.36 and its two-hundred day moving average is $48.84.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Needham & Company LLC reaffirmed a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Guggenheim started coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. Wolfe Research began coverage on Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price target for the company. Finally, Loop Capital lowered their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, Tempus AI currently has an average rating of “Moderate Buy” and an average price target of $58.55.

Institutional Trading of Tempus AI

Several institutional investors and hedge funds have recently modified their holdings of TEM. Vestmark Advisory Solutions Inc. raised its stake in Tempus AI by 148.3% during the 4th quarter. Vestmark Advisory Solutions Inc. now owns 122,450 shares of the company’s stock valued at $4,134,000 after purchasing an additional 73,132 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Tempus AI in the fourth quarter worth $3,757,000. Victory Capital Management Inc. bought a new position in shares of Tempus AI during the fourth quarter worth $216,000. SBI Securities Co. Ltd. purchased a new position in Tempus AI during the fourth quarter valued at $673,000. Finally, US Bancorp DE bought a new stake in Tempus AI in the 4th quarter valued at $80,000. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.